Health Promotion Research, Copenhagen University Hospital-Steno Diabetes Center Copenhagen, Herlev, Denmark.
Florence Nightingale Faculty of Nursing, Midwifery & Palliative Care, King's College London, London, UK.
Diabet Med. 2023 Oct;40(10):e15187. doi: 10.1111/dme.15187. Epub 2023 Aug 9.
To pilot-test an intervention, co-designed with people with type 1 diabetes (T1DM) and diabetes specialist nurses, to reduce diabetes distress (DD) in adults with T1DM and moderate-to-severe DD.
A group-based programme to reduce DD in people with T1DM and moderate-to-severe DD (REDUCE) was pilot-tested in four groups with five bi-weekly two and a half-hour meetings facilitated by two trained diabetes specialist nurses. Data collection included baseline and post-intervention questionnaires measuring DD and psychosocial outcomes and semi-structured interviews with participants post-intervention (n = 18). Data were analysed using descriptive statistics and systematic text condensation.
Twenty-five adults with T1DM participated in the study. The median age and diabetes duration of participants were 50 (IQR: 32;57.5) years and 26 (IQR: 18;45) years, respectively. Seventeen (68%) were women. The pilot study showed a significant reduction in DD (measured by Type 1 Diabetes Distress Scale) between baseline and post-intervention from 2.6 ± 0.7 to 1.9 ± 0.6 (mean ± SD) (p < 0.001). The largest reductions were seen on the subscales: powerlessness 1.2 ± 1.1, eating distress 0.9 ± 1.2 and fear of hypoglycaemia 0.8 ± 1.0 (mean ± SD). Significant improvements were also seen for quality of life, diabetes empowerment and emotion regulation. Qualitative data showed that REDUCE supported participants in verbalizing emotions and seeing worries in a more constructive perspective. Acknowledgement of negative diabetes experiences eased negative self-judgments. Sharing experiences among peers increased relatedness and reduced loneliness.
Participation in REDUCE was associated with significant reduction in DD and significant increase in quality of life. Larger scale studies are planned to determine sustained effectiveness of REDUCE.
与 1 型糖尿病(T1DM)患者和糖尿病专科护士共同设计干预措施,对 T1DM 成人中糖尿病困扰(DD)进行试点测试,以减少中度至重度 DD。
采用基于小组的方案对 T1DM 且中重度 DD 患者(RE-DUCE)进行 DD 干预,4 组参与者在 2 名经过培训的糖尿病专科护士的协助下,每两周进行 5 次为时 2 个半小时的会议。数据收集包括基线和干预后问卷,以测量 DD 和心理社会结果,以及参与者干预后(n=18)的半结构化访谈。使用描述性统计和系统文本压缩对数据进行分析。
25 名 T1DM 成人参加了研究。参与者的平均年龄和糖尿病病程中位数分别为 50(IQR:32;57.5)岁和 26(IQR:18;45)岁。17 名(68%)为女性。初步研究显示,DD(通过 1 型糖尿病困扰量表测量)在基线和干预后从 2.6±0.7 显著降低到 1.9±0.6(平均值±标准差)(p<0.001)。子量表中最大的降幅是:无力感 1.2±1.1,饮食困扰 0.9±1.2 和对低血糖的恐惧 0.8±1.0(平均值±标准差)。生活质量、糖尿病赋能和情绪调节也显著改善。定性数据表明,RE-DUCE 支持参与者表达情绪,并以更具建设性的视角看待担忧。对负面糖尿病经历的承认减轻了负面自我评价。同伴之间分享经验增加了关联性,减少了孤独感。
参与 REDUCE 与 DD 显著减少和生活质量显著提高相关。计划进行更大规模的研究以确定 REDUCE 的持续有效性。